Brii Biosciences Limited (2137.HK) News
Follow Brii Biosciences Limited (2137.HK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BRIEF — BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
Oct 15 (Reuters) — Brii Biosciences Ltd: Launch Of Brisc, An Sirna Therapeutics Discovery Platform Further company coverage: 2137.HK (reuters.briefs@thomsonreuters.com;)
NEWS | Oct 15, 2026, 11:34 AM UTC
L
Brii Biosciences Launches Dual — Targeting siRNA Drug Discovery Platform
Brii Biosciences launched BRiSC today, a proprietary discovery platform for next-generation, dual-targeting small interfering RNA therapies. The platform is designed to enable a single treatment to silence two distinct t
NEWS | Oct 15, 2026, 11:33 AM UTC